PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Metronidazole→

Metronidazole PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
443-48-1
Molecular formula
C6H9N3O3
Molecular weight
171.154 g/mol
Drug class
Nitroimidazole Antimicrobial
Mechanism of action
In susceptible anaerobic organisms, metronidazole is reduced to reactive intermediates that may interact with DNA, inhibiting DNA synthesis and causing DNA degradation and cell death. The precise mechanism is not fully established.
Indications / reported uses
  • Abscess
  • Amebiasis
  • Bacteroides Infections
  • Endocarditis, Bacterial
  • Enterocolitis, Pseudomembranous

Sources: US FDA — Metronidazole prescribing information (2026): microbiology and mechanism

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Metronidazole PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Metronidazole Permitted Daily Exposure (PDE) report (the Metronidazole PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Metronidazole Occupational Exposure Limit (OEL) report (the Metronidazole OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.